Comparison between ANG Lifesciences IPO and Manav infra projects IPO.
IPO Details
ANG Lifesciences IPO is a SME Fixed Price IPO proposed to list at BSE SME while Manav infra projects IPO is a SME Fixed Price proposed to list at NSE SME.
Issue Size and Price
The total issue size of ANG Lifesciences IPO is up to ₹11.39 Cr whereas the issue size of the Manav infra projects IPO is up to ₹5.23 Cr. The final issue price of ANG Lifesciences IPO is ₹80.00 per share and of Manav infra projects IPO is ₹30.00 per share.
IPO Timetable
ANG Lifesciences IPO opens on Aug 29, 2017, while Manav infra projects IPO opens on Sep 04, 2017. The closing date of ANG Lifesciences IPO and Manav infra projects IPO is Aug 31, 2017, and Sep 08, 2017, respectively.
Financials & KPIs
ANG Lifesciences IPO P/E ratio is , as compared to Manav infra projects IPO P/E ratio of .
Shares Offered
In the ANG Lifesciences IPO Retail Individual Investors (RII) are offered 7,12,000 shares while in Manav infra projects IPO retail investors are offered 7,12,000 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in ANG Lifesciences IPO and 0 shares in Manav infra projects IPO.
| | ANG Lifesciences IPO | Manav infra projects IPO |
|---|
| Anchor Investor Reservation | 0 shares | 0 shares |
| Market Maker Reservation | 76,800 shares | 92,000 shares |
| QIB | 0 shares | 0 shares |
| NII | 7,12,000 shares | 8,72,000 shares |
| RII | 7,12,000 shares | 8,72,000 shares |
| Employee | 0 shares | 0 shares |
| Total | 14,24,000 shares | 17,44,000 shares |
Bids Received (Subscription)
ANG Lifesciences IPO subscribed 8.25x in total, whereas Manav infra projects IPO subscribed 2.95x.
